Search

Background: Research about the long‐term outcomes of oesophagogastric devascularization and splenectomy (OGDS) to treat portal hypertension (PH) is scarce. This study aimed to evaluate the safety and long‐term treatment efficacy of OGDS, especially in elderly patients. Methods: During 2010–2016, open splenectomy and oesophagogastric devascularization (OSOD) and laparoscopic splenectomy and oesophagogastric devascularization were performed in 124 (group A) and 29 (group C) patients diagnosed with PH and liver cirrhosis, respectively. All patients aged less than 65 years. Besides, 39 patients aged 65 years or older undergoing open splenectomy and oesophagogastric devascularization were classified into group B. All clinical data were retrospectively analysed. Results: Compared with group A, patients in group C had longer operative time, less blood loss and shorter post‐operative hospitalization time. However, for perioperative data, there was no significant difference between group A and group B. During post‐operative follow‐up, compared with pre‐operative condition, all haematology and liver function parameters significantly changed, except for alanine aminotransferase. For post‐operative complications, only the portal vein system thrombosis rate was significantly higher in group C than group A. No significant difference was found in the overall survival rate among three groups, when non‐variceal‐rebleeding‐related deaths were excluded. Conclusion: OGDS remains safe and effective to treat PH secondary to liver cirrhosis and it can be performed successfully in elderly patients and achieve a curative effect that is not inferior to young patients. [ABSTRACT FROM AUTHOR]

Background: Hepatic angiomyolipoma (HAML) is a rare and difficult‐to‐diagnose liver tumour. The aim of this study was to summarize experiences in the management of HAML and to recommend a practical treatment strategy. Methods: We retrospectively studied 92 patients who were diagnosed with HAML and analysed the clinical presentation, histopathological features and treatment of the tumours encountered at our institute from May 2009 to June 2016. Results: The patients included 67 females and 25 males who underwent at least one radiographic examination. Sixty‐eight patients underwent radical hepatectomy, two patients underwent liver biopsy, and 22 patients were treated with radiofrequency ablation after liver biopsy. The tumour cells correspondingly expressed both melanoma cell markers (HMB45, MART‐1) and smooth muscle cell markers. Two patients were found to have tumour recurrence (2/92, 2.2%) after radical hepatectomy, and none of the patients died. Conclusion: Diagnosis of HAML depends on pathological findings. The treatment strategy for HAML should be selected according to the tumour size, liver biopsy, location and clinical symptoms of HAML. Patients should be followed closely after surgery because of the malignant potential of HAML. [ABSTRACT FROM AUTHOR]